Nick Lai is a Principal Scientist at Regeneron, where they lead early-stage formulation development and technology innovation for monoclonal antibody and gene therapy products. With seven years of hands-on experimental experience in biochemistry and developmental biology, they specialize in the novel activity and function of mammalian enzymes, neuro-developmental disorders, and adipogenic differentiation. Nick previously worked as a Scientist at Regeneron and held positions at Howard Hughes Medical Institute and Cytiva. They earned a PhD in Biochemistry from the University of Illinois Urbana-Champaign and are currently pursuing a Bachelor of Science in Life Science with a minor in Biotechnology at National Taiwan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices